PTC Therapeutics executive Mark Elliott Boulding disposes of $12,337 of common shares
PTCT•Executive Vice President and CLO Mark Elliott Boulding exercised options for 192 shares at $39.42 on Oct. 9, 2026, then sold them at a weighted average price of $64.26. He held 105,272 shares directly after the transactions.
1. Share transactions
Boulding exercised stock options for 192 PTC Therapeutics shares at $39.42 on Oct. 9, 2026, and sold 192 shares the same day at a weighted average price of $64.26. His directly held common stock totaled 105,272 shares after the transactions.
